Voriconazole pharmaceutical product
Original notice title
VORICONAZOLE
Opportunity Score
Why this score?
Opportunity
55 / 100
Complexity
45 / 100
Risk factors
Award criteria vary significantly between lots, with Lot 3 being 100% price while Lots 1 and 2 include quality sub-crit...
No estimated value, selection criteria, or required documents are provided in the notice. This increases uncertainty ab...
Deep Portfolio Analysis
Uses:
- Description
- Industries & Services
- Capabilities
- Market & Experience
- Certifications
Overview
Moderate opportunityKey Facts
- Supplies contract
- 3 lots
- Supply of Voriconazole in three forms: powder for solution for infusion (Lot 1), film-coated tablets (Lot 2), and powder for oral solution (Lot 3).
- Contract duration: 4 years for each lot.
Show full summary
Open tender by MercurHosp ASBL (Belgium) for the supply of Voriconazole in three pharmaceutical forms: powder for infusion, film-coated tablets, and powder for oral solution. The contract is divided into three lots for a duration of 4 years. No estimated value is provided. Submission deadline is 2026-07-14T09:00:00.000Z. Electronic submission is required, and the procedure language is French.
Risks
Award criteria vary significantly between lots, with Lot 3 being 100% price while Lots 1 and 2 include quality sub-crit...
No estimated value, selection criteria, or required documents are provided in the notice. This increases uncertainty ab...
Analysis may be incomplete
Only part of the procurement documentation was analyzed. Additional eligibility requirements, certificates, or submission documents may exist in the remaining tender documentation.
Key Requirements
Technical
- Open procedure.
Administrative
- Electronic submission is required via the specified platform.
- Tenders must be submitted in French (FRA).
Requirements may be incomplete.
Award Criteria
Lot 1
Lot 2
Lot 3
Lot 4
Lot 5
Lot 6
Lot 7
Lot 8
Lot 9
Buyer
Name
MercurHosp ASBL
Location
Erpent, BEL
Website
Buyer profile
Identifier
0543412311_1730
Lots (3)
LOT-0001
MH-JF-122025-VORICONAZOLE - 1
Voriconazole 200 MG en poudre pour solution pour perfusion (powder for solution for infusion).
Location
Category
Deadline
Award details
Value note
Show original TED data
Original TED description
Voriconazole 200 MG en poudre pour solution pour perfusion
LOT-0002
LOT-0002
Voriconazole en comprimés pelliculés (film-coated tablets) - inferred from overall procurement description; specific lot description not provided in structured data.
Location
Category
Deadline
Value note
LOT-0003
LOT-0003
Voriconazole en poudre pour solution buvable (powder for oral solution) - inferred from overall procurement description; specific lot description not provided in structured data.
Location
Category
Deadline
Value note
Procurement Details
- Publication date
- 07 Jun 2026
- Notice type
- Contract notice — standard
- Languages
- French
Reference metadata
- Notice subtype
- 16
- Notice version
- 1
- Legal basis
- 32014L0024
Reference IDs
- Tender ID
- 389538-2026
- Source notice ID
- 793b94d7-fc68-4545-b552-21edc5dcfd9b
Documents (2)
Similar tenders
Denmark – Pharmaceutical products – Amgros 2027 1.1051.b
Poland – Pharmaceutical products – Dostawa produktów leczniczych do SPZZOZ w Wyszkowie
Romania – Pharmaceutical products – MEDICAMENTE - PRODUSE FARMACEUTICE
Denmark – Pharmaceutical products – Amgros 2027 1.1052.b
Latvia – Pharmaceutical products – Par reģistrēto un nereģistrēto medikamentu piegādi Elektronisko iepirkumu sistēmas dalībniekiem
Spain – Pharmaceutical products – Suministro de Aflibercept (DOE) Intravítreo 40 mg/ml
Opportunity Score
Why this score?
Opportunity
55 / 100
Complexity
45 / 100
Risk factors
Award criteria vary significantly between lots, with Lot 3 being 100% price while Lots 1 and 2 include quality sub-crit...
No estimated value, selection criteria, or required documents are provided in the notice. This increases uncertainty ab...
Deep Portfolio Analysis
Uses:
- Description
- Industries & Services
- Capabilities
- Market & Experience
- Certifications